**Healthcare Global Enterprises Q3 Results 2025**
Healthcare Global Enterprises announced its Q3 results on February 14, 2025, reporting an 18.89% increase in topline revenue and a 22.46% rise in profit year-over-year. The company recorded a profit of ₹6.98 crore and revenue of ₹557.55 crore.
In comparison to the previous quarter, revenue saw a modest growth of 0.92%, while profit experienced a significant decline of 61.2%. Selling, general, and administrative expenses rose by 5.83% quarter-over-quarter and increased by 16.69% year-over-year. Operating income fell by 40.07% from the previous quarter and decreased by 8.05% year-over-year. The earnings per share (EPS) for Q3 stood at ₹0.49, reflecting a year-over-year increase of 19.51%.
Over the past week, Healthcare Global Enterprises has delivered a return of -6.66%, while the returns over the last six months and year-to-date are 37.49% and 0.06%, respectively. The company currently has a market capitalization of ₹6,823.1 crore, with a 52-week high of ₹567.7 and a low of ₹314.
As of February 16, 2025, among five analysts covering the company, four have issued a Buy rating, and one has given a Strong Buy rating, leading to a consensus recommendation of Buy.
**Healthcare Global Enterprises Financials**
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|———————-|———–|———–|————–|———–|————–|
| Total Revenue | 557.55 | 552.47 | +0.92% | 468.95 | +18.89% |
| Selling/General/Admin Expenses | 90.24 | 85.27 | +5.83% | 77.33 | +16.69% |
| Depreciation/Amortization | 56.52 | 49.74 | +13.63% | 44.16 | +27.99% |
| Total Operating Expense | 526.71 | 501.01 | +5.13% | 435.41 | +20.97% |
| Operating Income | 30.84 | 51.46 | -40.07% | 33.54 | -8.05% |
| Net Income Before Taxes | -3.32 | 7.65 | -111.93% | 11.06 | -129.84% |
| Net Income | 6.98 | 17.99 | -61.2% | 5.7 | +22.46% |
| Diluted Normalized EPS | 0.49 | 1.28 | -61.72% | 0.41 | +19.51% |
Stay informed on quarterly results with our results calendar.
